We have previously shown that microcell-mediated transfer of a der(9)t(X;9) chromosome, containing an almost complete human chromosome (HSA) 9 derived from the human fibroblast strain GM0705, into the Syrian hamster (Mesocricetus auratus) cell line BHK-191-5C suppressed the anchorage independence and tumorigenicity of the hybrids. Transfer of a normal HSA X did not have any effect on these phenotypes. Although the recipient cell line contained a 1:1 ratio of near-diploid and near-tetraploid cells, all hybrids retaining the der(9) chromosome were near-tetraploid, in contrast to hybrids retaining a normal X chromosome. In the present study, we have generated microcell hybrids by transferring another der(9)t(X;9) chromosome derived from the human fibroblast strain GM01429. This derivative chromosome contained a deletion on the short arm of HSA 9 and was also missing the distal part of the long arm of HSA 9 due to the involvement in a reciprocal (constitutive) translocation of this chromosome with HSA X. Cytogenetic analysis showed that all hybrid clones were near-tetraploid, confirming our previous finding. We also observed that the introduction of the deleted der(9) chromosome forced the hybrids to lose Syrian hamster chromosome 10. A soft agar test and nude mice assay indicated that none of the hybrids was suppressed for either anchorage independent growth or tumor formation. These data suggest that there is an antagonistic relationship between growth-promoting genes and antiproliferative genes. The observed dosage effects of both growth-promoting and growth-suppressing genes indicate that cellular growth may be a quantitative trait.   

1.
Freedman VH, Shin S: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3:355–359 (1974).
2.
Islam K, Islam MQ: Assignment of TK1 encoding thymidine kinase to Syrian hamster chromosome 9 by microcell-mediated chromosome transfer. Cytogenet Cell Genet 66:177–180 (1994).
3.
Islam MQ, Islam K, Levan G, Horvath G: Monochromosome transfers to Syrian hamster BHK cells via microcell fusion provide functional evidence for suppressor genes on human chromosome 9 both for tumorigenicity and for anchorage independence. Genes Chrom Cancer 13:115–125 (1995).
4.
Islam MQ, Levan G: A new fixation procedure for improved quality G-bands in routine cytogenetic work. Hereditas 107:127–130 (1987).
5.
Islam MQ, Szpirer J, Szpirer C, Islam K, Dasnoy J-F, Levan G: A gene for the suppression of anchorage independence is located in rat chromosome 5 bands q22-23, and the rat alpha-interferon locus maps at the same region. J Cell Sci 92:147–162 (1989).
6.
Klein KG, Bouck NP: The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for human fibrosarcoma line. Cancer Genet Cytogenet 73:109–121 (1994).
7.
Stanbridge EJ, Wilkinson J: Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. Proc natl Acad Sci, USA 75:1466–1469 (1978).
8.
Stanbridge EJ, Wilkinson J: Dissociation of anchorage independence from tumorigenicity in human cell hybrids. Int J Cancer 26:1–8 (1980).
9.
Vogelstein B, Fearon ER: The multistep nature of cancer. Trends Genet 9:138–141 (1993).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.